María Luisa Villanueva‐Peñacarrillo

Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms

Neşe I ̇meryüz, Berrak Ç. Yeğen, Ayhan Bozkurt et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 1997 · 422 citations · Full text

Gastrointestinal Pharmacology, Gastric Function, Immunology +19

Effect of GLP-1 Treatment on Bone Turnover in Normal, Type 2 Diabetic, and Insulin-Resistant States

Bernardo Nuche‐Berenguer, Paola Moreno, Pedro Esbrit et al. · Calcified Tissue International · 2009 · 188 citations

Bone Health, Glp-1 Treatment, Insulin Management +11

Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states

Bernardo Nuche‐Berenguer, Paola Moreno, Sergio Portal‐Núñez et al. · Regulatory Peptides · 2009 · 141 citations

Metabolic Syndrome, Insulin Signaling, Sclerostin +12

Presence of a functional receptor for GLP‐1 in osteoblastic cells, independent of the cAMP‐linked GLP‐1 receptor

Bernardo Nuche‐Berenguer, Sergio Portal‐Núñez, Paola Moreno et al. · Journal of Cellular Physiology · 2010 · 141 citations

Glucagon‐like peptide 1: A potent glycogenic hormone

Isabel Valverde, Mónica Morales, F. Clemente et al. · FEBS Letters · 1994 · 134 citations · Full text